B
Braidwell Portfolio holdings
AUM
$2.92B
1-Year Return
4.59%
This Quarter Return
-5.74%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.16B
AUM Growth
+$104M
(+3.4%)
Cap. Flow
-$1.21B
Cap. Flow
% of AUM
-38.14%
Top 10 Holdings %
Top 10 Hldgs %
35.35%
Holding
100
New
14
Increased
28
Reduced
11
Closed
11
Top Buys
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$25.9M |
| 2 |
89bio
ETNB
|
$24.6M |
| 3 |
Thermo Fisher Scientific
TMO
|
$24.5M |
| 4 |
Boston Scientific
BSX
|
$23.6M |
| 5 |
Immunocore
IMCR
|
$22.8M |
Top Sells
| 1 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$47.8M |
| 2 |
Biogen
BIIB
|
$34.7M |
| 3 |
Align Technology
ALGN
|
$30.2M |
| 4 |
Aclaris Therapeutics
ACRS
|
$30.1M |
| 5 |
Glaukos
GKOS
|
$26.2M |
Sector Composition
| 1 | Healthcare | 51.8% |
| 2 | Consumer Staples | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Pulmonx
LUNG
$70.9M
| $10.2M | 0.32% |
988,559
-10,803
| -1% | -$112K |
|
52
The Beauty Health Co
SKIN
$254M
| $9.79M | 0.31% |
+1,626,236
| New | +$9.79M |
|
53
Amgen
AMGN
$151B
| $9.73M | 0.31% |
+36,200
| New | +$9.73M |
|
|
SGEN
54
DELISTED
Seagen Inc. Common Stock
SGEN
| $9.02M | 0.28% |
42,497
| – | – |
|
55
Krystal Biotech
KRYS
$4.33B
| $8.99M | 0.28% |
77,497
-163,902
| -68% | -$19M |
|
56
Replimune Group
REPL
$454M
| $8.34M | 0.26% |
487,520
| – | – |
|
|
AGEN
57
Agenus
AGEN
$137M
| $7.13M | 0.23% |
315,352
+80,455
| +34% | +$1.82M |
|
|
RYZB
58
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $6.17M | 0.19% |
+277,778
| New | +$6.17M |
|
59
ALX Oncology
ALXO
$57.8M
| $6M | 0.19% |
1,249,900
| – | – |
|
60
Adaptive Biotechnologies
ADPT
$1.98B
| $5.27M | 0.17% |
967,690
+319,239
| +49% | +$1.74M |
|
|
61
Aclaris Therapeutics
ACRS
$224M
| – | – |
-2,901,194
| Closed | -$30.1M |
|
62
Alphatec Holdings
ATEC
$2.45B
| – | – |
-25,431
| Closed | -$457K |
|
|
63
Biogen
BIIB
$20.5B
| – | – |
-121,942
| Closed | -$34.7M |
|
64
Crinetics Pharmaceuticals
CRNX
$3.23B
| – | – |
-650,312
| Closed | -$11.7M |
|
65
Esperion Therapeutics
ESPR
$510M
| – | – |
-895,949
| Closed | -$1.25M |
|
66
Merus
MRUS
$5.01B
| $0 | ﹤0.01% |
1,901,337
+358,175
| +23% | – |
|
67
Nuvation Bio
NUVB
$1.17B
| – | – |
-4,122,900
| Closed | -$7.42M |
|
68
Rhythm Pharmaceuticals
RYTM
$6.95B
| – | – |
-843,087
| Closed | -$13.9M |
|
|
SLRN
69
DELISTED
ACELYRIN
SLRN
| – | – |
-500,000
| Closed | -$10.5M |
|
70
Vir Biotechnology
VIR
$714M
| – | – |
-728,549
| Closed | -$17.9M |
|
|
MRTX
71
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-240,625
| Closed | -$8.69M |
|
|
DICE
72
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| – | – |
-1,029,901
| Closed | -$47.8M |
|